CHEMIPAMS CO., LTD.

the company profile for CHEMIPAMS CO., LTD., including its classification and the English translation.

---

CHEMIPAMS CO., LTD. (주식회사 케미팜스) 기업 소개

(주)케미팜스 (CHEMIPAMS CO., LTD.) 는 대한민국에 기반을 둔 제약 관련 기업입니다. 주요 사업 분야는 다음과 같습니다:

1. 의약품 원료 (APIs - Active Pharmaceutical Ingredients) 개발 및 제조: 핵심 사업으로, 자체 연구개발 역량을 바탕으로 다양한 종류의 고품질 의약품 원료를 개발하고 생산합니다. GMP (Good Manufacturing Practice) 기준에 부합하는 생산 시설을 운영하며 엄격한 품질 관리를 통해 제품을 공급합니다.

2. 의약품 중간체 (Pharmaceutical Intermediates) 생산: 완제 의약품 또는 API 합성에 필요한 중간체를 개발하고 제조합니다.

3. 연구개발 (R&D): 신규 API 공정 개발, 기존 공정 개선, 고객 맞춤형 합성 연구 등 활발한 연구개발 활동을 수행합니다.

4. 수출입: 자체 생산한 API 및 중간체를 해외 시장에 수출하고, 필요한 원료나 기술을 수입하기도 합니다.

분류: 공장 (제조업체)

(주)케미팜스는 자체적인 연구개발 능력과 GMP 인증을 받은 생산 시설을 보유하고 직접 의약품 원료 및 중간체를 제조하는 기업입니다. 따라서 핵심 정체성은 제조업체(공장) 입니다. 물론, 자사 제품을 국내외에 판매하고 수출하므로 무역 활동도 병행하지만, 직접 생산을 기반으로 한다는 점에서 제조업체로 분류하는 것이 가장 정확합니다.

---

English Translation

CHEMIPAMS CO., LTD. Company Profile

CHEMIPAMS CO., LTD. is a pharmaceutical-related company based in South Korea. Its main business areas include:

1. Development and Manufacturing of Active Pharmaceutical Ingredients (APIs): This is its core business. Leveraging its own research and development capabilities, the company develops and produces various types of high-quality APIs. It operates production facilities compliant with Good Manufacturing Practice (GMP) standards and supplies products under strict quality control.

2. Production of Pharmaceutical Intermediates: The company develops and manufactures intermediates required for the synthesis of finished pharmaceutical products or APIs.

3. Research and Development (R&D): CHEMIPAMS actively engages in R&D activities, including the development of new API processes, improvement of existing processes, and custom synthesis research for clients.

4. Export and Import: The company exports its self-manufactured APIs and intermediates to overseas markets and may also import necessary raw materials or technologies.

Classification: Factory (Manufacturer)

CHEMIPAMS CO., LTD. possesses its own R&D capabilities and GMP-certified production facilities, directly manufacturing APIs and intermediates. Therefore, its core identity is a manufacturer (factory). While it also engages in trading activities by selling and exporting its own products domestically and internationally, its foundation in direct production makes classifying it as a manufacturer the most accurate description.

here are the product and service categories typically associated with CHEMIPAMS CO., LTD., based on their business focus, translated into English:

CHEMIPAMS CO., LTD. primarily produces and offers services related to:

APIs (Active Pharmaceutical Ingredients): These are the core components in finished drug products that produce the intended therapeutic effect.

Pharmaceutical Intermediates: These are chemical compounds that are steps in the synthesis process towards creating the final API.

Custom Synthesis: They synthesize specific chemical compounds on demand for clients according to provided specifications or research needs.

Contract Manufacturing (CMO/CDMO Services): They manufacture APIs or intermediates under contract for other pharmaceutical companies, often involving process development and scaling up production (Contract Development and Manufacturing Organization).

R&D Services: Related to the development of new synthetic routes and processes for pharmaceutical chemicals.

In summary, CHEMIPAMS focuses on the research, development, and manufacturing of key chemical components for the pharmaceutical industry, both for their own pipeline and as a service provider for other companies. They specialize in complex organic synthesis.